Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management cut its Agilent Technologies stake by 75.3% in the second quarter, selling 31,934 shares and retaining 10,454 shares valued at approximately $1.39 million.
• Analyst sentiment remains positive, with Agilent holding a consensus “Moderate Buy” rating and an average price target of $160.24; several firms recently raised targets or upgraded the stock.
• Agilent reported quarterly EPS of $1.49 versus the $1.41 estimate, while revenue rose 10% year over year to $1.83 billion. The company also declared a quarterly dividend of $0.255 per share, equating to a 0.7% yield.

Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 75.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,454 shares of the medical research company's stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Agilent Technologies were worth $1,389,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of A. State Street Corp boosted its holdings in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company's stock worth $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC raised its holdings in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company's stock valued at $1,006,519,000 after acquiring an additional 25,139 shares during the period. Morgan Stanley lifted its position in shares of Agilent Technologies by 15.9% in the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company's stock valued at $686,049,000 after acquiring an additional 692,202 shares in the last quarter. Norges Bank purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $549,158,000. Finally, Cantillon Capital Management LLC boosted its stake in Agilent Technologies by 0.8% in the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company's stock worth $423,945,000 after purchasing an additional 23,493 shares during the period.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. Piper Sandler started coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a "neutral" rating and a $150.00 target price on the stock. TD Cowen raised their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research report on Thursday, May 28th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Sunday, August 2nd. Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a "hold" rating and a $135.00 price target on the stock. Finally, Robert W. Baird increased their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 26th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $160.24.

Agilent Technologies Trading Down 0.5%

Agilent Technologies stock opened at $148.55 on Friday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $41.95 billion, a P/E ratio of 29.83, a P/E/G ratio of 2.64 and a beta of 1.25. The company's fifty day simple moving average is $135.38 and its 200-day simple moving average is $125.56.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company earned $1.31 earnings per share. Agilent Technologies's quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies's payout ratio is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source